Guidelines on Psychosis and Schizophrenia
We have been busy responding to requests from NICE to give our view on Guidelines being produced by them. Today we were pleased to be able to comment on the Guidelines on Psychosis and Schizophrenia. These Guidelines are not new, but the old set has been reviewed thoroughly and it wasn’t felt necessary to produce any new guideline. However, we have suggested that there does need to be a new set produced because the existing document doesn’t address the fact that some patients who have been diagnosed as having Psychosis may very well be suffering from lack of B12. Hopefully our input will lead to NICE reconsidering their decision not to produce new guidelines.
Guidelines on Neurological Conditions
Two weeks ago, NICE asked us to comment on their new Guidelines on Neurological Conditions where we able to point out that any patient with neurological issues could have low or very low B12. And we also took that opportunity to raise awareness that there are serious problems with the current tests used to determine the B12 status of patients and that there was no consensus on what constituted a deficiency or sub-clinical deficiency.
We continue to lobby NICE to conduct a thorough Review of the way in which Pernicious Anaemia is Diagnosed and Treated which will hopefully lead to a new set of Guidelines for the disease. There are some signs that this is now being considered at the highest level though we still have a long way to go. We will, of course, keep you informed of any developments.